CD4+ T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness
- PMID: 29126798
- DOI: 10.1016/j.immuni.2017.10.009
CD4+ T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness
Abstract
CD4+ T cells optimize the cytotoxic T cell (CTL) response in magnitude and quality, by unknown molecular mechanisms. We here present the transcriptomic changes in CTLs resulting from CD4+ T cell help after anti-cancer vaccination or virus infection. The gene expression signatures revealed that CD4+ T cell help during priming optimized CTLs in expression of cytotoxic effector molecules and many other functions that ensured efficacy of CTLs throughout their life cycle. Key features included downregulation of PD-1 and other coinhibitory receptors that impede CTL activity, and increased motility and migration capacities. "Helped" CTLs acquired chemokine receptors that helped them reach their tumor target tissue and metalloprotease activity that enabled them to invade into tumor tissue. A very large part of the "help" program was instilled in CD8+ T cells via CD27 costimulation. The help program thus enhances specific CTL effector functions in response to vaccination or a virus infection.
Keywords: CD4 T cell help; CD8 T cell; CTL differentiation; coinhibition; costimulation; migration; transcriptome; tumor immunity; vaccination; virus infection.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
CD27 Agonism Plus PD-1 Blockade Recapitulates CD4+ T-cell Help in Therapeutic Anticancer Vaccination.Cancer Res. 2016 May 15;76(10):2921-31. doi: 10.1158/0008-5472.CAN-15-3130. Epub 2016 Mar 28. Cancer Res. 2016. PMID: 27020860
-
CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production.J Clin Invest. 2010 Jan;120(1):168-78. doi: 10.1172/JCI40178. Epub 2009 Dec 1. J Clin Invest. 2010. PMID: 19955658 Free PMC article.
-
Tumor-Unrelated CD4 T Cell Help Augments CD134 plus CD137 Dual Costimulation Tumor Therapy.J Immunol. 2015 Dec 15;195(12):5816-26. doi: 10.4049/jimmunol.1502032. Epub 2015 Nov 11. J Immunol. 2015. PMID: 26561553 Free PMC article.
-
CD4+ T cell help in cancer immunology and immunotherapy.Nat Rev Immunol. 2018 Oct;18(10):635-647. doi: 10.1038/s41577-018-0044-0. Nat Rev Immunol. 2018. PMID: 30057419 Review.
-
CD4+ Cytotoxic T cells - Phenotype, Function and Transcriptional Networks Controlling Their Differentiation Pathways.Immunol Lett. 2022 Jul;247:27-42. doi: 10.1016/j.imlet.2022.05.001. Epub 2022 May 11. Immunol Lett. 2022. PMID: 35568324 Review.
Cited by
-
Cathelicidin-Related Antimicrobial Peptide Regulates CD73 Expression in Mouse Th17 Cells via p38.Cells. 2020 Jun 26;9(6):1561. doi: 10.3390/cells9061561. Cells. 2020. PMID: 32604872 Free PMC article.
-
Biological factors driving colorectal cancer metastasis.World J Gastrointest Oncol. 2024 Feb 15;16(2):259-272. doi: 10.4251/wjgo.v16.i2.259. World J Gastrointest Oncol. 2024. PMID: 38425391 Free PMC article. Review.
-
CD4+ T cells are homeostatic regulators during Mtb reinfection.bioRxiv [Preprint]. 2023 Dec 21:2023.12.20.572669. doi: 10.1101/2023.12.20.572669. bioRxiv. 2023. PMID: 38187598 Free PMC article. Preprint.
-
OX40 agonism enhances PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrum.Cell Rep Med. 2023 Mar 21;4(3):100939. doi: 10.1016/j.xcrm.2023.100939. Epub 2023 Feb 15. Cell Rep Med. 2023. PMID: 36796366 Free PMC article.
-
MiR-195 restrains lung adenocarcinoma by regulating CD4+ T cell activation via the CCDC88C/Wnt signaling pathway: a study based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and bioinformatic analysis.Ann Transl Med. 2019 Jun;7(12):263. doi: 10.21037/atm.2019.05.54. Ann Transl Med. 2019. PMID: 31355230 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
